Page 81 - GHES-3-3
P. 81

Global Health Economics and
            Sustainability
                                                                                        Pharmaceutical system in Iraq


               in Iraqi Kurdistan. BMC International Health and Human   global-health-estimates-leading-causes-of-dalys  [Last
               Rights, 10:14.                                     accessed on 2024 Sep 01].
               https://doi.org/10.1186/1472-698x-10-14         World Health Organisation and Government of Iraq. (2009). The
                                                                  Government of Iraq and WHO Joint Program Review Mission
            Torpy, J.M., Burke A.E., & Glass, R.M. (2009). Coronary heart
               disease risk factors. JAMA. 302(21):2388.          (JPRM),the First Round Discussions Held Inside Iraq Since
                                                                  2001. World Health Organisation - Regional Office for the
               https://doi.org/10.1001/jama.302.21.2388           Eastern Mediterranean. Available from: https://www.emro.
            Underwood, G. (2020). Country Focus: Iraq’s Pharma Industry   who.int/ iraq-press-releases/2010/thegovernmentofiraqand
               Sees Upward Trajectory. Pharmaphorum. Available from:   whojointprogramreviewmissionjprm.html [Last accessed
               https://pharmaphorum.com/views -analysis-market-access/  on 2024 Sep 01].
               country-focus-iraq-pharma-industry [Last accessed on   World  Health  Organisation,  & Alwan, A.  (2004).  The  Current
               2024 Sep 01].                                      Situation, Our Vision for the Future and Areas of Work.
                                                                   nd
            UNICEF, & World Bank. (2020). Assessment of COVID-19   2   ed. Geneva, Switzerland: World Health Organisation.
               Impact on Poverty and Vulnerability in Iraq. Available from:   Available  from:  https://www.who.int/hac/crises/  irq/
               https://www.unicef.org/iraq/media/ 1181/file/assessment%20  background/iraq_health_in_iraq_  second_edition.
               of%20covid- 19%20impact%20on%20poverty%20 and%20   pdf?ua=1 [Last accessed on 2024 Sep 01].
               vulnerability%20in%20Iraq.pdf [Last accessed on 2024 Sep   World Health Organisation. (2010). Strengthening the
               01].                                               Pharmaceutical Industry and Utilization of Local Grown
            United  Nations  Department  of  Economic  and  Social  Affairs   Medical Plants in Iraq. Geneva, Switzerland: World Health
               Population  Division.  (2022).  World  Population  Prospects.   Organisation.
               United Nations. Available from: https://population.un.org/  World Health Organisation. (2013a). Country Cooperation
               wpp [Last accessed on 2024 Sep 01].                Strategy for WHO and Iraq: 2012–2017  1  January 2013.
            United States of America Department of Commerce. (2018).   Cairo, Egypt: Regional Office for the Eastern Mediterranean.
               Healthcare Resource Guide: Iraq. Washington DC., USA:   World Health Organisation. (2013b). WHO Global Surveillance
               United  States of  America Department  of  Commerce.   and Monitoring System. Available from: https://www.who.
               Available  from  https://www.2016.export.gov/  industry/  int/who -global-surveillance-and-monitoring-system [Last
               health/healthcareresourceguide/  eg_main_116238.as [Last   accessed on 2024 Sep 01].
               accessed on 2024 Sep 01].
                                                               World Health Organisation. (2021). Noncommunicable diseases
            USAID.  (2006). Iraq  Competitiveness  Analysis: Final Report.   in Iraq. World Health Organisation - Regional Office for the
               Washington, DC, USA: USAID. Availabe from: https://pdf.  Eastern Mediterranean. Geneva, Switzerland: World Health
               usaid.gov/pdf_docs/pnadh732.pdf [Last accessed on 2024   Organisation. Available from:  https://www.emro.who.int/
               Sep 01].                                           iraq/priority -areas/noncommunicable-diseases.html [Last
            Vandoros,  S.,  &  Stargardt,  T.  (2013).  Reforms  in  the  Greek   accessed on 2024 Sep 01].
               pharmaceutical market during the financial crisis.  Health   World Health Organisation. (2023). Global Health Expenditure
               Policy, 109(1):1-6.
                                                                  Database. World Health Organisation Global Health
               https://doi.org/10.1016/j.healthpol.2012.08.016    Expenditure Database. Available from: https://apps.who.int/
                                                                  nha/database [Last accessed on 2024 Sep 01].
            World Health Organisation (WHO). (2020). Global Health
               Estimates: Leading Causes of  Dalys.  World Health   Zebari, A. (2013). Modernization of Drug Distribution in
               Organisation. Available from  https://www.who.int/data/  Kurdistan: Is it Possible to Implement the Swedish Drug
               gho/data/  themes/mortality-and-global-health-estimates/   Distribution System in Kurdistan? Sweden: Umeå University




















            Volume 3 Issue 3 (2025)                         73                  https://doi.org/10.36922/GHES025110025
   76   77   78   79   80   81   82   83   84   85   86